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Abstract
Human parechoviruses (HPeVs) are widespread pathogens causing a wide spectrum of diseases. HPeVs belong to the family
Picornaviridae, and 14 genotypes are known. We conducted a case–control study to investigate the role of HPeV in acute gastroen-
teritis. HPeV was detected and quantiﬁed using real-time RT-PCR, and then genotyped by sequencing of the nested RT-PCR prod-
uct of the VP3/VP1 partial gene. HPeV was found in both the case and control groups (29.4% and 15.3% respectively, p 0.006). Six
HPeV genotypes (HPeV1, HPeV3, HPeV4, HPeV5, HPeV6, and HPeV8) were detected. Nine positive samples could not be
sequenced with negative genotyped RT-PCR. HPeV1 and HPeV3 were the most prevalent genotypes, and co-infection was common
in the case group. No statistically signiﬁcant differences in either viral load or the rate of HPeV1 and HPeV3 infection were found
between the two groups. Additionally, no signiﬁcant differences were found in fever rates, vomiting rates or mean duration and
frequency of diarrhoea and vomiting between the positive and negative case groups with HPeV1 or HPeV3. Multivariate logistic
regression analysis indicated that there was no association between the HPeV1 or HPeV3 infection and acute gastroenteritis. Multi-
ple genotypes of HPeVs were highly prevalent in Chinese children. One potential new HPeV genotype was identiﬁed, but needs to
be conﬁrmed further by the picoma study group. However, the present study does not support a causative role of HPeV1 and
HPeV3 in acute gastroenteritis.
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Introduction
Human parechoviruses (HPeVs) are single-stranded, posi-
tive-sense RNA viruses in the Parechovirus genus within the
large Picornaviridae family. To date, 14 HPeV genotypes,
eight (HPeV1–8) with the full genome sequence published
and two (HPeV10 and HPeV14) the partial genome
sequence published http://www.picornastudygroup.com/types/
parechovirus/hpev.htm, have been found in human infec-
tions, mostly in young children with acute gastroenteritis
[1]. However, the epidemiology and the roles of HPeV1–6
[2–9], especially HPeV7 [10], HPeV8 [11], HPeV10 [12],
and HPeV14 [13], as human pathogens remain poorly
understood.
A recent study suggested that HPeVs may not constitute
the primary factor responsible for epidemics of viral enteri-
tis, and rather are observed on a sporadic, endemic basis in
children who normally remain undiagnosed [14]. This suppo-
sition was directly conﬁrmed by a study in Norway [15].
Most studies have assessed the prevalence of HPeV in chil-
dren without a well-deﬁned control [13,16,17]. Therefore,
the role of HPeV in gastroenteritis remains to be clariﬁed
[1]. In this study, we investigated the prevalence and genetic
diversity of HPeV infection in children in Lanzhou, China,
and examined the relationship between different genotypes
of HPeV and gastroenteritis.
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Materials and Methods
Study participants and sample collection and processing
Two hundred and eighty-six children hospitalized with diar-
rhoea and 98 asymptomatic children who visited the First
Hospital of Lanzhou University (Lanzhou, China) between
July 2006 and June 2007 were recruited for this study.
Informed consent was obtained from the parents of all chil-
dren, and the ethics committee of the hospital approved the
study protocol. All of the children were <5 years of age.
Diarrhoea was deﬁned as three or more episodes of loose
stools in the previous 24–72 h [18]. Members of the control
group were asymptomatic without fever, diarrhoea, vomiting
or respiratory symptoms in the previous 3-week period [19].
Controls were selected by the frequency-matching method
for age, and were followed up by telephone. Children who
displayed the above-mentioned clinical symptoms during the
week after the initial examination were excluded. Stool
samples were collected and stored at )70C until further
analysis. Human Group A rotaviruses, human caliciviruses
(HuCV), astroviruses, and Human Bocavirus (HBOV) adeno-
viruses were screened in a previous study [20].
RNA extraction
Viral RNA was extracted from 140 lL of 10% faecal suspen-
sion in phosphate-buffered saline, with a QIAamp Viral RNA
Mini kit (Qiagen, Hilden, Germany), according to the manu-
facturer’s instructions. The elution volume was 50 lL, and
extracted RNA was stored at )70C.
HPeV detection and quantiﬁcation
HPeV was detected and quantiﬁed with a broad-range real-
time RT-PCR assay. The assay was performed in a Rotor-
Gene 3000 real-time thermal cycling system (Corbett
Research, Du¨sseldorf, Australia), with the methods described
by Baumgarte et al. [14]. A standard curve obtained with
synthetic RNA standard was used for calculating approximate
RNA concentrations, with an assumption of 100% efﬁciency
of RNA recovery during the puriﬁcation step.
HPeV genotyping
For HPeV genotyping, positive samples were ampliﬁed by
nested RT-PCR with two sets of primers [21]: set A, outer
VP3/VP1 sense and antisense primers 5¢-GAYAATGCYATM-
TAYACWATYTGTGA-3¢ and 5¢ ACWGTRAARATRTCHA-
CATTSATDG-3¢; and set B, VP3/VP1 inner sense and antisense
primers 5¢-TTYTCMACHTGGATGMGGAARAC-3¢ and 5¢-
DGGYCCATCATCYTGWGCTGA-3¢. The reaction condi-
tions for the two rounds of ampliﬁcation were performed as
described by Harvala et al. [21]. Ampliﬁed DNA was puriﬁed
and then sequenced by Invitrogen, Karsruhe, Germany.
Sequence analysis and accession numbers
The nucleotide and deduced amino acid sequences of the
VP3/VP1 partial gene were compared with those of HPeV
prototype strains available through GenBank. Phylogenetic
analyses were conducted with MEGA, version 3.1 (http://
www.megasoftware.net/). The 90 partial sequences of the
VP3/VP1 gene were submitted to GenBank (accession num-
bers FJ763350–FJ763439).
Statistical analysis
Statistically signiﬁcant differences in infection rates were
tested with a chi-square test and Fisher’s exact test. Statisti-
cally signiﬁcant differences between group means were
tested with a Student’s t-test and a log-normal Student’s
t-test. The association between acute gastroenteritis and
different HPeV genotypes was tested by logistic regression
analysis. Data analysis was performed using SPSS,
version 13.0 (SPSS, Chicago, IL, USA).
Results
Characteristics of case and control groups
All 384 children in the case and control groups were
<5 years of age (mean age ± standard deviation, 11.38 ± 9.5
months and 14.43 ± 17.7 months, respectively). The boy/girl
ratios were 1.8 : 1 and 1.0 : 1, respectively. No statistically
signiﬁcant differences in mean age (p 0.106) were found
between the two groups. However, for sex (p 0.012) the
differences were statistically signiﬁcant.
Prevalence of HPeV in children with and without acute
gastroenteritis
In total, 84 of 286 (29.4%) hospitalized children and 15 of 98
(15.3%) asymptomatic children were infected with HPeV
(p 0.006). All 99 HPeV-positive samples were subject to VP3/
VP1 PCR and sequencing. Ninety HPeV-positive samples were
successfully genotyped as either HPeV1, HPeV3, HPeV4,
HPeV5, HPeV6, or HPeV8. HPeV1 accounted for 51.2% (43/
84) and 53.3% (8/15) in the case and control groups, respec-
tively. In the case group, HPeV3 was the second most predom-
inant strain (25/84), followed by HPeV4 (4/84), and two
HPeV6 cases and one HPeV8 case were identiﬁed. In the con-
trol group, the numbers of HPeV3 and HPeV4 infections were
the same (both 3/15), and only one HPeV5 case was identiﬁed;
nine HPeV-positive samples, all from the case group, could not
be genotyped with negative genotyped RT-PCR.
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HPeV1 was frequently identiﬁed during the autumn–winter
season, with a peak from October to December. Similarly,
HPeV3 was frequently identiﬁed during the autumn season,
with a peak in October. For HPeV4, HPeV5, HPeV6, and
HPeV8, no seasonal distribution patterns were observed,
probably because of small sample sizes. However, HPeV1,
HPeV3, HPeV4 and HPeV6 can be all be found occasionally
in the summer season. Interestingly, all HPeV genotypes in
this study, except HPeV3, were less prevalent during the
spring season (Fig. 1a). More HPeV4 infections than HPeV1
and HPeV3 infections were identiﬁed at younger ages; 85.7%
of the HPeV4-infected children were younger than 9 months.
For HPeV1 and HPeV3, only 47.1% and 46.4% of the infected
children were younger than 9 months, and no differences
were observed in age distribution between the two geno-
types (Fig. 1b).
When the present data were merged with our previous
data [20], we found that, in the case group, 71.4% (60/84) of
the HPeV-positive samples also contained other enteric
viruses. Speciﬁcally, 53 were co-infected with a second virus,
and seven displayed triple infections. Rotavirus and HuCV
were the most frequently co-detected viruses (Fig. 2). In the
control group, two of 15 (13.3%) HPeV-positive cases were
co-infected with rotavirus. Co-infection rates for HPeV1,
HPeV3 and HPeV4 between the case group and the control
group were 74.4% vs. 12.5%, 72.0% vs. 33.3%, and 50.0% vs.
0.0%, respectively (Table 1). The differences in co-infection
rates between the case group and the control group were
statistically signiﬁcant (71.4% vs. 13.3%, p 0.001, by
chi-square test).
Quantitative analysis of HPeV RNA
In the case group, HPeV load ranged from 2.01 · 102 to
1.84 · 106 copies/lL stool, whereas in the control group it
ranged from 3.50 · 103 to 1.27 · 107 copies/lL stool. No
statistically signiﬁcant differences were observed in HPeV1,
HPeV3 and HPeV4 loads between the two groups (p >0.05)
(Table 1). For HPeV5, HPeV6, and HPeV8, no statistical anal-
yses were performed, because of small sample sizes. Interest-
ingly, the two highest viral loads were found in asymptomatic
control subjects.
Phylogenetic characterization of HPeV genotypes
The region ampliﬁed by the VP3/VP1 primers was highly vari-
able [21]. HPeV1, HPeV3, HPeV4, HPeV5, HPeV6 and
HPeV8 were identiﬁed in our study (Fig. 3). Unfortunately,
the VP3/VP1 partial gene sequence of the prototype strains
HPeV10 and HPeV14 are not available. The majority of VP3/
VP1 genes in our study were found to cluster closely
together with prototype HPeV strains. Remarkably, analysis
of contemporary strains of HPeV1 and those most similar to
the prototype strain (Harris) showed HPeV1 variants falling
into two genetically distinct clusters. The mean divergence of
nucleotides is 22.5% between the two clades, which was the
greatest divergence in the observed HPeV types. HPeV3
strains in our study were found to be very genetically close.
Speciﬁcally, one strain (49330-Lanzhou) was segregated to be
0
2
4
6
8
10
12
14
16
Month
N
o.
 o
f i
so
la
te
s
N
o.
 o
f i
so
la
te
s
HPeV1
HPeV3
HPeV4
HPeV5
HPeV6
HPeV8
0
5
10
15
20
25
30
35
0–6 7–12 13–18 19–24 25–60
Age (month)
HPeV1
HPeV3
HPeV4
HPeV5
HPeV6
HPeV8
Jul
/06
Au
g/0
6
Se
p/0
6
Oc
t/0
6
No
v/0
6
De
c/0
6
Jan
/07
Fe
b/0
7
Ma
r/0
7
Jun
/07
(a)
(b)
FIG. 1. (a) Seasonal distribution of all known human parechovirus
(HPeV) genotypes. (b) Age distribution of all known HPeV genotypes.
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FIG. 2. Pathogen composition of co-infection in 84 human parecho-
virus (HPeV)-positive children (case group). HBoV; HuCV, human
calicivirus; RV, rotavirus.
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a single sequence branching which could not be assigned to a
speciﬁc HPeV cluster. This strain had the highest nucleotide
identity (76.1%) with HPeV4 and the lowest (69.1%) with
HPeV8. Its genetic similarity with to Ljungan Virus, a rodent
parechovirus, was only 55.7%.
Association of different HPeV genotypes with acute
gastroenteritis
In our study, none of the HPeV-positive patients had respira-
tory symptoms. No statistically signiﬁcant differences were
found in HPeV1, HPeV3 and HPeV4 infection rates between
the case group and the control group (p >0.05) (Table 1).
Additionally, no statistically signiﬁcant differences were
observed in HPeV1 and HPeV3 infection rates between chil-
dren with gastroenteritis of undetectable viral aetiology
(13.6% and 6.8%, respectively) and children infected with
other common viral gastroenteritis agents (15.8% and 9.8%,
respectively) (human Group A rotavirus, HuCV, astroviruses,
and/or adenoviruses) (p >0.05). In the case group, patients
were assigned to the following groups: HPeV1-positive,
HPeV1-negative (samples from children with gastroenteritis
and no HPeV1 detected), HPeV3-positive, and HPeV3-nega-
tive (samples from children with gastroenteritis and no
HPeV3 detected). Among these groups, no statistically signiﬁ-
cant differences were found in fever rates, vomiting rates,
and mean duration and frequency of diarrhoea and vomiting
(p >0.05) (Table 2). In addition, no statistically signiﬁcant dif-
ferences in clinical symptoms were found between children
infected with rotavirus alone and children co-infected with
rotavirus and HPeV1 or HPeV3 (p >0.05) (Table 2).
The univariate logistic regression analysis indicates that age
distribution, sex, rotavirus infection and HuCV infection have
strong associations with acute gastroenteritis. In considering
the association between acute gastroenteritis and different
HPeV genotypes, multivariate logistic regression analysis was
performed with the factors mentioned above. The age variant
was divided into two groups: <24 months and ‡24 months.
The results of the analysis showed no association between
acute gastroenteritis and HPeV1 (OR 1.55; 95% CI 0.62–3.89;
p 0.35), HPeV3 (OR 2.39; 95% CI 0.63–9.16; p 0.20), or
HPeV4 (OR 1.04; 95% CI 0.17–6.29; p 0.96).
Discussion
This article reports a high prevalence of HPeV infection in
children hospitalized with acute diarrhoea (29.4%) or in
asymptomatic children (15.3%) younger than 5 years in
Lanzhou city. However, no comparisons can be made
between our study and several previous studies on HPeV
prevalence [9,14,22], because the latter were primarily based
on culture isolates obtained via different methods and/or
involved both children and adults. One exception is a study
by Benschop et al. [13], which showed a similar prevalence
of HPeV to that of our control group (16.3% and 15.3%,
respectively). In this study, detection assays were performed
directly on stool samples acquired exclusively from children
under 5 years oof age. The inconsistencies are unlikely to be
caused by cross-contamination, because of strict control
measures in nucleic acid extraction and PCR analysis.
In the present study, HPeV1, HPeV3, HPeV4–6 and
HPeV8 were detected. In accordance with epidemiological
data on HPeV1 [23–25], HPeV3 [4], and HPeV4–6 [13,26],
HPeV1 was identiﬁed as the predominant strain, followed by
HPeV3. In contrast, HPeV4–6 were less prevalent than
HPeV1 and HPeV3, both locally in the Lanzhou region and
globally. HPeV3 was mainly found during the autumn season.
This result is not in accordance with a previous study, in
which HPeV3 was mainly found during the summer season
[13]. In this study, HPeV4 infection peaked at an earlier age
than did both HPeV1 and HPeV3, and no differences were
found with regard to age distribution. However, in a previ-
ous study, HPeV3 was associated with increased infection
rates at a younger age [13]. These differences indicate that
HPeV may have different epidemiological features associated
with geographical area. All of these isolates were obtained
over a short period of time and from one area, and yearly
variation may also occur, so further research is needed.
TABLE 1. Comparison of detection rates, co-infection rates and virus loads of human parechovirus (HPeV)1, HPeV3 and
HPeV4 between the case group and the control group
Group
No. (%) of HPeV-positive participants No. (%) of co-infections Virus load (copies/lL)
HPeV1 HPeV3 HPeV4 HPeV1a HPeV3 HPeV4 HPeV1 HPeV3 HPeV4
Case 43/286 (15.0) 25/286 (8.7) 4/286 (1.4) 32/43 (74.4) 18/25 (72.0) 2/4 (50.0) 1.22 · 105 2.1 · 105 2.47 · 104
Control 8/98 (8.2) 3/98 (3.1) 3/98 (3.1) 1/8 (12.5) 1/3 (33.3) 0/3 (0.0) 2.93 · 106 7.73 · 103 5.11 · 105
No statistically signiﬁcant differences were observed (p >0.05), except for co-infection rates of HPeV1 between the two groups (p 0.002). Co-infection means that HPeV-
positive samples were also infected with other enteric viruses. The viral load is the mean of the HPeV-positive samples.
1566 Clinical Microbiology and Infection, Volume 17 Number 10, October 2011 CMI
ª2011 The Authors
Clinical Microbiology and Infection ª2011 European Society of Clinical Microbiology and Infectious Diseases, CMI, 17, 1563–1569
In the present study, nine HPeV-positive stool samples
were unable to be genotyped, owing to low virus titres
or degradation. It is also possible that these samples may
contain novel HPeV genotypes that the current genotyping
assay could not identify. In addition, the obvious separation
between the contemporary strains of HPeV1 and those
most similar to the prototype strain (Harris) was in good
agreement with a previous study by Benschop et al. [27].
The lower divergence observed in HPeV3 strains may be
attributable to the low frequency of recombination
observed in this genotype [27]. Importantly, the 49330-
Lanzhou strain could not be assigned to a speciﬁc HPeV
cluster on the basis of the thresholds of 18% divergence
for nucleotides dividing the intratype and intertype catego-
ries [21], and may be a novel genotype. Unfortunately, the
whole genome sequence was not obtained, and further
characterization is required. Clearly, increased surveillance
and access to type identiﬁcation methods will greatly
expand the conﬁrmed but unpublished HPeV types in the
future, such as the conﬁrmed but unpublished HPeV9 and
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FIG. 3. Phylogenetic tree of the VP3/
VP1 partial gene sequences of the 90
human parechovirus (HPeV) strains
from faecal samples. Prototype strains
are in bold, and the GenBank accession
numbers are indicated. Strains marked
with black circles are from asymptom-
atic children. All other strains are from
children with gastroenteritis. A sample
(49330-Lanzhou) that could not be
assigned to a speciﬁc HPeV cluster is
indicated by a black triangle.
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HPeV11–13, available at http://www.picornastudygroup.com/
types/parechovirus/hpev.htm.
In our study, no statistically signiﬁcant differences in the
prevalence or viral loads of HPeV1, HPeV3 and HPeV4 were
observed between children with and without gastroenteritis.
However, two of the 15 HPeV-positive stool samples from
the control group had the highest viral loads among all
samples. This result is in accordance with the study by Bau-
mgarte et al. [14], in which one of the highest viral loads
occurred in an asymptomatic child. In this regard, our results
do not strengthen the results of previous ﬁndings [4,9,21],
and suggest that HPeV is not associated with gastroenteritis.
Certainly, it cannot be excluded that HPeV may multiply
greatly in asymptomatic children in the immunocompromised
situation. Furthermore, co-infection with HPeV and another
virus was common (71.4%) in the gastroenteritis group, with
rotavirus being the most common partner. No statistically
signiﬁcant differences in HPeV1 and HPeV3 infection rates
were found between children with gastroenteritis of unde-
tectable viral aetiology and children infected with other com-
mon viral gastroenteritis agents. Univariate logistic
regression analysis indicated that age, sex, rotavirus infection
and HuCV infection have strong associations with acute
gastroenteritis. No association was found between HPeV1 or
HPeV3 infection and acute gastroenteritis when these factors
were included in further multivariate logistic regression
analysis. These results support the hypothesis that HPeV1
and HPeV3 are ‘innocent bystanders’ and play no role in
gastroenteritis.
In this study no signiﬁcant differences in fever rate,
vomiting rate or mean duration and frequency of diar-
rhoea and vomiting were found between the positive and
negative case groups with HPeV1 or HPeV3. This result
indicates that infection with HPeV1 and HPeV3 does not
signiﬁcantly inﬂuence the severity of gastroenteritis, and
argues against a causative role of HPeV1 and HPeV3 in
acute gastroenteritis. It should be noted that one previous
study reported that there was no signiﬁcant association
between infections and coughing, sneezing, fever, diarrhoea
or vomiting, and concluded that HPeVs frequently infect
infants at an early age without causing disease [15]. The
present results for HPeV1 and HPeV3 were in good
agreement with it. An association between HPeV4, HPeV5,
HPeV6 and HPeV8 and gastroenteritis could not be estab-
lished, owing to the small sample size. However, more
study is needed to clarify whether HPeV (or some HPeV
types) is an opportunistic pathogen or a latent virus in the
gastrointestinal tract that is reactivated by other viral
infections.
In summary, high prevalences of HPeV and six known
HPeV genotypes were found in children with and without
gastroenteritis in Lanzou, and one new HPeV genotype
(49330-Lanzhou) was also identiﬁed. Despite the frequent
detection of HPeV in faecal samples worldwide, our results
do not support a causative role of HPeV1 and HPeV3 in
gastroenteritis. The exact clinical associations of HPeV
infection should be investigated in future studies. Additional
research, including case–control studies with larger samples,
is necessary.
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TABLE 2. Comparison of clinical symptoms of human parechovirus (HPeV)1 and HPeV3 infection between different groups of
children with gastroenteritis
Group
No. of
children
No. of children
with fever
No. of children
with vomiting
Duration of diarrhoea
(days), mean ± SD
Frequency of diarrhoea
(episodes/day), mean ± SD
Positive for HPeV1 43 18 31 3.91 ± 5.11 7.40 ± 3.44
Negative for HPeV1 243 90 136 4.29 ± 5.01 6.51 ± 3.12
Positive for HPeV3 25 9 18 3.40 ± 2.29 6.28 ± 2.92
Negative for HPeV3 261 99 149 4.31 ± 5.20 6.68 ± 3.20
Infected with RV alone 85 44 58 4.53 ± 5.58 7.26 ± 3.31
Infected with RV + HPeV1 22 11 18 3.77 ± 3.85 8.23 ± 3.82
Infected with RV alone 85 44 58 4.53 ± 5.58 7.26 ± 3.31
Infected with RV + HPeV3 11 6 9 3.82 ± 3.06 6.73 ± 3.61
RV, rotavirus; SD, standard deviation.
No statistically signiﬁcant differences were observed (p >0.05).
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